Tilray Brands, Inc. (2HQ.DE)

2.35 €

+0.03 (+1.29%)
Symbol 2HQ.DE
Price 2.35 €
Beta 0.000
Volume Avg. 0.03M
Market Cap 421.477M
Shares () -
52 Week Range 2.315-62.18
1y Target Est -
DCF Unlevered 2HQ.DE DCF ->
DCF Levered 2HQ.DE LDCF ->
ROE -122.88% Strong Sell
ROA -28.66% Sell
Operating Margin -
Debt / Equity 153.00% Buy
P/E 25.82 Strong Buy
P/B 0.90 Buy


Consensus EPS

Upgrades & Downgrades

Mr. Irwin David Simon
Drug Manufacturers—Specialty & Generic
Frankfurt Stock Exchange

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.